- Home
- GPRO vs COYA Comparison
GPRO vs COYA Comparison
Compare GPRO & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRO
- COYA
- Stock Information
- Founded
- GPRO 2004
- COYA 2020
- Country
- GPRO United States
- COYA United States
- Employees
- GPRO N/A
- COYA N/A
- Industry
- GPRO Industrial Machinery/Components
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- GPRO Consumer Discretionary
- COYA Health Care
- Exchange
- GPRO Nasdaq
- COYA Nasdaq
- Market Cap
- GPRO 118.4M
- COYA 107.0M
- IPO Year
- GPRO 2014
- COYA 2022
- Fundamental
- Price
- GPRO $1.35
- COYA $6.15
- Analyst Decision
- GPRO
- COYA Strong Buy
- Analyst Count
- GPRO 0
- COYA 4
- Target Price
- GPRO N/A
- COYA $16.50
- AVG Volume (30 Days)
- GPRO 21.7M
- COYA 59.2K
- Earning Date
- GPRO 08-11-2025
- COYA 08-12-2025
- Dividend Yield
- GPRO N/A
- COYA N/A
- EPS Growth
- GPRO N/A
- COYA N/A
- EPS
- GPRO N/A
- COYA N/A
- Revenue
- GPRO $746,731,000.00
- COYA $423,452.00
- Revenue This Year
- GPRO N/A
- COYA $40.52
- Revenue Next Year
- GPRO $6.79
- COYA N/A
- P/E Ratio
- GPRO N/A
- COYA N/A
- Revenue Growth
- GPRO N/A
- COYA N/A
- 52 Week Low
- GPRO $0.40
- COYA $4.65
- 52 Week High
- GPRO $2.37
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- GPRO 58.88
- COYA 51.12
- Support Level
- GPRO $1.16
- COYA $5.60
- Resistance Level
- GPRO $1.36
- COYA $6.28
- Average True Range (ATR)
- GPRO 0.12
- COYA 0.41
- MACD
- GPRO -0.02
- COYA -0.04
- Stochastic Oscillator
- GPRO 59.38
- COYA 49.11
About GPRO GoPro Inc.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.